MIM
INFI

MetLife Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

MetLife Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33,123
Closed -$113K – 2574
2021
Q3 		$113K Buy
+33,123
New +$102K ﹤0.01% 2388

Other funds holding INFI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MetLife Investment Management's INFI Position: Q4 2021 in Review

MetLife Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 33,123 shares — an estimated $113K sold.

MetLife Investment Management first reported a position in INFI in Q3 2021 and held it in 1 quarter. The position peaked at $113K in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

  • MetLife Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 33,123 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $113K.
  • MetLife Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • MetLife Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $113K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.